Prostate Specific Antigen (PSA) Test Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead
Discover trends, market shifts, and competitive outlooks for the prostate specific antigen (psa) test industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Is the Estimated Market Size of the Prostate Specific Antigen (PSA) Test Market In 2029?
The market size for the prostate specific antigen (PSA) test has seen a swift expansion recently. The market, valued at $4.15 billion in 2024, is projected to escalate to $4.66 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.1%. The notable growth in the historic period can be credited to factors such as heightened awareness, a growing elderly population, advancements in medical and pharmaceutical sectors, and clinical recommendations.
The market size of the prostate specific antigen (PSA) test is anticipated to witness significant expansion in the coming years. By 2029, the market is projected to reach $7.29 billion, with a compound annual growth rate (CAGR) of 11.9%. This predicted growth during the forecast period can be credited to factors such as the enhancement in test precision, the personalized medicine approach, and the global increase in the elderly population. Key trends during the same period are expected to include a shift towards combining biomarkers, technological advances, at-the-point-of-care testing, integrating digital health, along with an emphasis on early detection and prevention.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12576&type=smp
What Are the Major Market Drivers Behind the Rising Adoption of Prostate Specific Antigen (PSA) Test Market?
The acceleration in the rate of prostate cancer occurrences has been predicted to drive the advancement of the prostate-specific antigen (PSA) test market. Prostate cancer is found when there are cancer cells in the prostate gland, which is a part of both male and female reproductive systems. The PSA test, which measures the quantity of prostate-specific antigen in the bloodstream, is a commonly used method to screen for prostate cancer in men, aiding in early identification and risk evaluation. To illustrate, the American Society of Clinical Oncology (ASCO), a professional oncology group based in the US, reported in March 2023 that approximately 288,300 men in the US were found to have prostate cancer, and about 34,700 individuals passed away from it in 2023. Thus, the PSA test market is growing due to the increased detection of prostate cancer.
Which Key Market Segments Comprise the Prostate Specific Antigen (PSA) Test Market and Drive Its Revenue Growth?
The prostate specific antigen (PSA) test market covered in this report is segmented –
1) By Type: Clinical Laboratory Improvement Amendments (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Fluorescence Immunoassay (FIA), Other Types
2) By Application: Screening, Post-Treatment Monitoring, Other Applications
3) By End User: Hospitals, Diagnostic Centers, Research Institutes, Other End Users
Subsegments:
1) By Clinical Laboratory Improvement Amendments (CLIA): CLIA Waived Tests, Non-CLIA Tests
2) By Enzyme-Linked Immunosorbent Assay (ELISA): Sandwich ELISA Kits, Competitive ELISA Kits
3) By Fluorescence Immunoassay (FIA): Point-Of-Care FIA, Laboratory-Based FIA
4) By Other Types: Chemiluminescent Immunoassay (CLIA), Radioimmunoassay (RIA)
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=12576&type=smp
Which Areas Are Leading Regions in the Prostate Specific Antigen (PSA) Test Market Expansion Across the Globe?
North America was the largest region in the prostate specific antigen (PSA) test market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate specific antigen (PSA) test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Are the Strategic Trends Steering theProstate Specific Antigen (PSA) Test Market Direction?
The rising trend in the prostate-specific antigen (PSA) test market is primarily driven by technological advancements. Major players in the market are leveraging this trend by developing state-of-the-art screening test tools to maintain their market dominance. In February 2023, for example, LynxDx Inc., an American diagnostic firm, introduced MyProstateScore 2.0, a non-invasive urine prostate cancer screening test. This pioneering test employs a mix of 18 biomarkers, inclusive of the innovative gene fusion T2:ERG, to create an individualised risk profile for each patient. The test also provides accurate stratified risk assessment information, which can guide medical decisions for patients with raised prostate-specific antigen (PSA) levels or inconsistent results from a digital rectal exam (DRE). This tool holds the potential to significantly enhance prostate cancer screening and treatment processes.
View the full report here:
How Is the Prostate Specific Antigen (PSA) Test Market Conceptually Defined?
The prostate-specific antigen (PSA) test is a blood test that quantifies the presence of prostate-specific antigen in the body. This test is primarily used to screen for and monitor prostate cancer in men and measures the level of prostate-specific antigen in the blood.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12576
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
